UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response

Annals of hematology, 2020-11, Vol.99 (11), p.2599-2609

2020

Volltextzugriff (PDF)

Immunological Characterization and Antibacterial Function of Persisting Granulocytes in Leukemic Patients Receiving Pulse Cytosine Arabinoside-Consolidation Chemotherapy on Days 1, 3, and 5

Journal of Immunology, 2006-02, Vol.176 (3), p.1759-1768

2006

Volltextzugriff (PDF)

Immunoglobulin light chain amyloidosis: Short tutorial in screening, early detection, risk assessment and response evaluation

Memo - Magazine of European medical oncology, 2021-03, Vol.14 (1), p.103-110

2021

Volltextzugriff (PDF)

Short tutorial. Treatment options in light chain amyloidosis and monoclonal gammopathy of renal significance

Memo - Magazine of European medical oncology, 2021-03, Vol.14 (1), p.80-88

2021

Volltextzugriff (PDF)

PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms

American journal of hematology, 2022-04, Vol.97 (4), p.390-400

2022

Volltextzugriff (PDF)

Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms

American journal of hematology, 2023-05, Vol.98 (5), p.770-783

2023

Volltextzugriff (PDF)

Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

American journal of hematology, 2017-09, Vol.92 (9), p.885-891

2017

Volltextzugriff (PDF)

Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers

Journal of cancer research and clinical oncology, 2021-01, Vol.147 (1), p.205-212

2021

Volltextzugriff (PDF)

Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact

British journal of haematology, 2014-03, Vol.164 (6), p.822-833

2014

Volltextzugriff (PDF)

Monoclonal gammopathy of undetermined significance (MGUS): where is the hidden danger? Definition and work-up

Memo - Magazine of European medical oncology, 2021-03, Vol.14 (1), p.76-79

2021

Volltextzugriff (PDF)

A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination

Journal of Allergy and Clinical Immunology, 2005-05, Vol.115 (5), p.1010-1016

2005

Volltextzugriff (PDF)

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Annals of hematology, 2024-07, Vol.103 (7), p.2299-2310

2024

Volltextzugriff (PDF)

ASH 2018—Highlights in Multiple Myeloma

Memo - Magazine of European medical oncology, 2019-09, Vol.12 (3), p.203-206

2019

Volltextzugriff (PDF)

Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: Importance for allergenic activity

Journal of Allergy and Clinical Immunology, 2006-06, Vol.117 (6), p.1336-1343

2006

Volltextzugriff (PDF)

ASH highlights 2022—multiple myeloma

Memo - Magazine of European medical oncology, 2023-09, Vol.16 (3), p.160-164

2023

Volltextzugriff (PDF)

Highly potent and selective 5-lipoxygenase inhibition by new, simple heteroaryl-substituted catechols for treatment of inflammation

Biochemical pharmacology, 2023-02, Vol.208, p.115385-115385, Article 115385

2023

Volltextzugriff (PDF)

Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patients

Cancer, 2023-11, Vol.129 (21), p.3466-3475

2023

Volltextzugriff (PDF)

α‐Tocopherol long‐chain metabolite α‐13’‐COOH affects the inflammatory response of lipopolysaccharide‐activated murine RAW264.7 macrophages

Molecular nutrition & food research, 2015-08, Vol.59 (8), p.1524-1534

2015

Volltextzugriff (PDF)

Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite α-(13'-hydroxy)-6-hydroxychroman

Free radical biology & medicine, 2015-12, Vol.89, p.952-962

2015

Volltextzugriff (PDF)

Vaccination with genetically modified birch pollen allergens: Immune and clinical effects on oral allergy syndrome

Journal of allergy and clinical immunology, 2007-04, Vol.119 (4), p.1013-1016

2007

Volltextzugriff (PDF)

N‐terminal B‐type natriuretic peptide (NT‐proBNP) is associated with disease severity in multiple myeloma

European journal of clinical investigation, 2018-04, Vol.48 (4), p.n/a

2018

Volltextzugriff (PDF)

P-283: TRIATLON - triple class exposed/refractory multipLe myeloma patients: a real world analysis (RWA) from the Austrian Myeloma Registry (AMR)

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S193-S194

2022

Volltextzugriff (PDF)

Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells

The FASEB journal, 2005-06, Vol.19 (8), p.960-962

2005

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)
Berichte
(1)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response

Immunological Characterization and Antibacterial Function of Persisting Granulocytes in Leukemic Patients Receiving Pulse Cytosine Arabinoside-Consolidation Chemotherapy on Days 1, 3, and 5

Immunoglobulin light chain amyloidosis: Short tutorial in screening, early detection, risk assessment and response evaluation

Short tutorial. Treatment options in light chain amyloidosis and monoclonal gammopathy of renal significance

PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma

Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms

Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers

Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact

Monoclonal gammopathy of undetermined significance (MGUS): where is the hidden danger? Definition and work-up

A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

ASH 2018—Highlights in Multiple Myeloma

QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross‐sectional analysis of the randomized AGMT 02 study

Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: Importance for allergenic activity

ASH highlights 2022—multiple myeloma

Highly potent and selective 5-lipoxygenase inhibition by new, simple heteroaryl-substituted catechols for treatment of inflammation

Risk as a pattern over time: Delineation of time-dependent risk factors in biological, psychological, and social variables in cancer patients

α‐Tocopherol long‐chain metabolite α‐13’‐COOH affects the inflammatory response of lipopolysaccharide‐activated murine RAW264.7 macrophages

Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite α-(13'-hydroxy)-6-hydroxychroman

Vaccination with genetically modified birch pollen allergens: Immune and clinical effects on oral allergy syndrome

N‐terminal B‐type natriuretic peptide (NT‐proBNP) is associated with disease severity in multiple myeloma

P-283: TRIATLON - triple class exposed/refractory multipLe myeloma patients: a real world analysis (RWA) from the Austrian Myeloma Registry (AMR)

Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells

Aktive Filter

Suchergebnisse filtern